Paper Details
- Home
- Paper Details
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.
Author: ScottLesley J, Swainston HarrisonTracy
Original Abstract of the Article :
Ziprasidone (Geodon, Zeldox) is an atypical antipsychotic agent with a unique neurotransmitter receptor-binding profile. The oral formulation is indicated for the treatment of adult patients with schizophrenia and the intramuscular formulation for the control of acute agitation in these patients. In...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.2165/00023210-200620120-00006
データ提供:米国国立医学図書館(NLM)
Ziprasidone: A Novel Antipsychotic for Schizophrenia and Schizoaffective Disorder
Schizophrenia and schizoaffective disorder, like a desert mirage, can create a confusing and distorted reality for those who experience them. This study, like a desert explorer seeking a new path through a challenging landscape, explores the use of ziprasidone, a novel atypical antipsychotic, for the treatment of these conditions. The authors examine the unique neurotransmitter receptor-binding profile of ziprasidone and its effectiveness in treating various aspects of schizophrenia and schizoaffective disorder.
Ziprasidone Offers a Promising Treatment Option
This study, like a desert oasis offering a source of relief and hope, reveals that ziprasidone is an effective treatment option for patients with schizophrenia and schizoaffective disorder. The authors found that ziprasidone, available in both oral and intramuscular formulations, was effective in reducing symptoms and improving overall functioning in patients.
Understanding the Benefits and Risks of Ziprasidone
This research, like a desert guidebook highlighting potential hazards and resources, emphasizes the importance of understanding the benefits and risks associated with ziprasidone. While the authors highlight its effectiveness in treating symptoms, they also acknowledge the potential for QT interval prolongation and provide guidance for monitoring patient safety.
Dr.Camel's Conclusion
Schizophrenia and schizoaffective disorder can create a challenging and unpredictable environment for patients and their families. This study, like a camel caravan navigating a vast and unforgiving desert, offers hope for improved treatment options. The findings suggest that ziprasidone, like a hidden spring providing a vital source of water, could be a valuable tool for managing these complex conditions. It's a reminder that even in the seemingly barren landscape of mental health, there are often opportunities for progress and hope.
Date :
- Date Completed 2007-04-16
- Date Revised 2018-11-13
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.